In this study, CD3+CD4+ and CD4+/CD8+ ratios were significantly reduced, and CD3+CD8+ was increased in patients with multiple myeloma at the initial and progressive stages, which was consistent with the previous reports [23]. This evidence concerns the gene CD4 and AL amyloidosis.